Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Biopharmaceutical company GW Pharmaceuticals PLC nets $273.1mm in follow-on offering

Executive Summary

GW Pharmaceuticals PLC netted $273.1mm in a follow-on public offering of 2.8mm American Depository Shares (ADSs; each ADS equals 12 ordinary shares) and the full exercise of the 420k over-allotment option at $90 per ADS. The company is developing a product portfolio of cannabinoid medicines for a wide range of indications.

Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies